Mesangial Cells Initiate Compensatory Renal Tubular Hypertrophy Via IL-10-induced TGF-beta Secretion: Effect of the Immunomodulator AS101 on This Process
Overview
Physiology
Authors
Affiliations
The present study investigated the role of IL-10 produced by the mesangial cells in postnephrectomy compensatory renal growth and the effect of the immunomodulator AS101 on this process. One hundred forty unilateral nephrectomized and sham-operated male Sprague-Dawley rats were treated by AS101 or PBS before and after surgery. The results show that secretion of IL-10 and TGF-beta by mesangial cells isolated from the remaining kidneys was increased significantly, compared with those of control and sham animals. Moreover, TGF-beta secretion by mesangial cells was increased after the addition of exogenous recombinant IL-10 and inhibited in the presence of neutralizing anti-IL-10 antibodies. In vivo, compensatory growth of the remaining kidneys was associated with significant increase in IL-10 content in renal tissues and plasma. Immunohistochemical studies show that IL-10 was produced by mesangial cells. Elevated IL-10 levels were followed by the rise in TGF-beta content in plasma and renal tissue. AS101 treatment decreased IL-10 and TGF-beta expression in plasma and kidney tissues and results in 25% reduction in the fresh and fractional kidney weight and decreased hypertrophy of tubular cells (protein/DNA ratio, morphometric analysis). Taken together, these data demonstrate that TGF-beta production by mesangial cells is IL-10 dependent. Mesangial cells are the major source of IL-10 in kidneys. AS101, by inhibiting the activity of IL-10, decreases TGF-beta production by mesangial cells, thus limiting compensatory tubular cell hypertrophy.
Aparicio-Trejo O, Rojas-Morales P, Avila-Rojas S, Leon-Contreras J, Hernandez-Pando R, Jimenez-Uribe A Int J Mol Sci. 2020; 21(18).
PMID: 32899919 PMC: 7555424. DOI: 10.3390/ijms21186512.
Multifunctional Natural Polymer Nanoparticles as Antifibrotic Gene Carriers for CKD Therapy.
Midgley A, Wei Y, Zhu D, Gao F, Yan H, Khalique A J Am Soc Nephrol. 2020; 31(10):2292-2311.
PMID: 32769144 PMC: 7609017. DOI: 10.1681/ASN.2019111160.
Zheng R, Zhu R, Li X, Li X, Shen L, Chen Y Front Physiol. 2018; 9:1229.
PMID: 30233405 PMC: 6131671. DOI: 10.3389/fphys.2018.01229.
Cambier L, Giani J, Liu W, Ijichi T, Echavez A, Valle J Hypertension. 2018; 72(2):370-380.
PMID: 29866742 PMC: 6043385. DOI: 10.1161/HYPERTENSIONAHA.118.11239.
YB-1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation.
Wang J, Djudjaj S, Gibbert L, Lennartz V, Breitkopf D, Rauen T J Cell Mol Med. 2017; 21(12):3494-3505.
PMID: 28664613 PMC: 5706504. DOI: 10.1111/jcmm.13260.